Patient Demographic and Clinical Characteristics
| Patient characteristic | Value |
| Sex (n) | |
| Male | 31 (58%) |
| Female | 22 (42%) |
| Histology (n) | |
| Adenocarcinoma | 21 (40%) |
| Squamous cell carcinoma | 24 (45%) |
| Not specified | 8 (15%) |
| T stage (n) | |
| T1 | 6 (11%) |
| T2 | 14 (27%) |
| T3 | 15 (28%) |
| T4 | 17 (32%) |
| TX | 1 (2%) |
| N stage (n) | |
| N0 | 11 (21%) |
| N1 | 4 (8%) |
| N2 | 33 (62%) |
| N3 | 5 (9%) |
| Tumor stage (n) | |
| IB | 3 (6%) |
| IIB | 5 (9%) |
| IIIA | 24 (45%) |
| IIIB | 21 (40%) |
| Median duration between PET and treatment (d) | 45 (range, 0–174) |
| Median radiotherapy dose (Gy) | 64 (range, 55–64) |
| Median chemotherapy cycles (n) | 4 (range, 1–6) |